Background: Antiphospholipid antibodies (aPLs) are antibodies directed against components of the cell membrane and can be associated with clinical features or be asymptomatic in 1-5% of the population.
Objective: The objective of this study is to investigate the frequency of aPL positivity based on body mass index (BMI).
Methods: This is a retrospective analysis of all aPL testing done in a tertiary center between 2010 and 2020.
Objectives: To evaluate Epileptic drop attacks (EDAs) treatment options among pediatric neurologists in Saudi Arabia (SA) and to develop a recommendation scheme for the management of EDAs in SA. Epileptic drop attacks are one of the most pharmaco-resistant epileptic seizures. The different approaches to EDA treatment are influenced by a variety of factors, including pharmaceutical availability, costs, side effects, treating physicians' experience and personal preferences.
View Article and Find Full Text PDF